The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis
European Respiratory Journal · 2026
DOI: 10.1183/13993003.01890-2025 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Afolarin A Otunla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery and Interventional Science, University College London, London, UK. Hauptthemen laut MEDLINE: Lung Transplantation, Graft Survival, HLA Antigens, Histocompatibility Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung transplantation offers definitive treatment for end-stage pulmonary disease, but graft survival remains inferior to other solid organ transplants. A key driver of graft loss is antibody-mediated rejection triggered by donor–recipient human leukocyte antigen (HLA) mismatch. Although HLA matching is not currently used in lung allocation due to organ scarcity and urgency of transplant, understanding its impact could improve risk stratification and outcomes. This study aimed to assess the effect of HLA compatibility on lung graft survival using a large multicentre database and to explore whether this relationship varies by transplant indication.
Methods
We conducted a retrospective cohort study of 37 091 lung transplant recipients in the UNOS/OPTN database. Patients were grouped by HLA mismatch (0–2 versus 3–6) and stratified by indication. Multivariate Cox regression and Kaplan–Meier analyses assessed adjusted associations with graft survival.
Results
HLA-DR mismatch was associated with increased graft failure risk at 1 year (hazard ratio (HR) 1.38, 95% CI 1.00–1.90; p=0.048) and 5 years (HR 1.20, 95% CI 1.03–1.40; p=0.020). Stratified analyses showed this effect was found exclusively in those with COPD or interstitial pneumonia. In COPD, HLA-DR mismatch significantly increased failure risk at 1 year (HR 2.88, 95% CI 1.34–6.19; p=0.007). In interstitial pneumonia, 5-year graft failure risk also rose with mismatch (HR 1.28, 95% CI 1.03–1.58; p=0.026).
Conclusions
The present study is the first to demonstrate that HLA-DR mismatch adversely affects lung graft survival in an indication-specific manner. This finding supports the development of indication-specific strategies in post-transplant surveillance and immunosuppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Surgery and Interventional Science, University College London, London, UK.
- Department of Surgery, University of Chicago, Chicago, IL, USA.
- Imperial College School of Medicine, Imperial College London, London, UK.
- Department of Life Sciences, Imperial College London, London, UK.
- Department of Critical Care, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Surgery and Cancer, Imperial College London, London, UK.
ORCID-Profile: Afolarin A Otunla, Daniel Dolan, Justin Salciccioli
Zitieren
APA
Otunla, A. A., Shanmugarajah, K., Mukhtar, G., Nabulsi, S., Dolan, D., Salciccioli, J., Marshall, D. C., Madariaga, M. L., & Shalhoub, J. (2026). The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis. European Respiratory Journal. https://doi.org/10.1183/13993003.01890-2025
Vancouver
Otunla AA, Shanmugarajah K, Mukhtar G, Nabulsi S, Dolan D, Salciccioli J, et al. The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis. European Respiratory Journal. 2026. doi:10.1183/13993003.01890-2025
BibTeX
@article{Otunla2026,
author = {Otunla, Afolarin A and Shanmugarajah, Kumaran and Mukhtar, Ghazel and Nabulsi, Sarah and Dolan, Daniel and Salciccioli, Justin and Marshall, Dominic C and Madariaga, Maria Lucia and Shalhoub, Joseph},
title = {The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.01890-2025}
}
EUVIMED